We are live on ! Find out more
WVP

Worth Venture Partners Portfolio holdings

AUM $31.6M
1-Year Est. Return 28.5%
This Fund
S&P 500
This Quarter Est. Return
+23.78%
1 Year Est. Return
+28.5%
3 Year Est. Return
+102.5%
5 Year Est. Return
+128.77%
10 Year Est. Return
–
AUM
$185M
AUM Growth
+$16.5M
Cap. Flow
-$100M
Cap. Flow %
-54.06%
Top 10 Hldgs %
35.61%
Holding
185
New
26
Increased
36
Reduced
26
Closed
56

Top Buys

Rank Stock Value
1
ELVA
Electrovaya
ELVA
+$2.28M
2
PROF
Profound Medical
PROF
+$1.53M
3
SCPH
scPharmaceuticals
SCPH
+$1.33M
4
LPSN icon
LivePerson
LPSN
+$1.23M
5
RCAT icon
Red Cat Holdings
RCAT
+$1.07M

Top Sells

Rank Stock Value
1
AVNW icon
Aviat Networks
AVNW
+$2.34M
2
MRAM icon
Everspin Technologies
MRAM
+$2.08M
3
MKL icon
Markel Group
MKL
+$1.23M
4
BWEN icon
Broadwind
BWEN
+$793K
5
ARGX icon
argenx
ARGX
+$737K

Sector Composition

Rank Sector Weight
1 Healthcare 21.35%
2 Technology 13.11%
3 Financials 6.55%
4 Industrials 6.29%
5 Real Estate 1.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LFMD icon
126
LifeMD
LFMD
$180M
– –
-10,269
Closed -$64.2K
MDXH icon
127
MDxHealth
MDXH
$23.4M
– –
-11,872
Closed -$33.7K
MKL icon
128
Markel Group
MKL
$23.3B
– –
-835
Closed -$1.23M
MRAM icon
129
Everspin Technologies
MRAM
$362M
– –
-211,862
Closed -$2.08M
NLY icon
130
Annaly Capital Management
NLY
$17.2B
– –
-14,200
Closed -$267K
NOTE
131
DELISTED
FiscalNote
NOTE
– –
-1,864
Closed -$46.5K
NVEC icon
132
NVE Corp
NVEC
$595M
– –
-8,813
Closed -$724K
RCUS icon
133
PUT
Arcus Biosciences
RCUS
$3.47B
– –
-10,900
Closed -$3.81K
RIVN icon
134
Rivian
RIVN
$22.2B
– –
-18,092
Closed -$439K
RSKD icon
135
Riskified
RSKD
$698M
– –
-64,524
Closed -$289K
SNCR
136
DELISTED
Synchronoss Technologies
SNCR
– –
-2,338
Closed -$20.2K
SNDX icon
137
Syndax Pharmaceuticals
SNDX
$1.7B
– –
-10,900
Closed -$158K
SNDX icon
138
PUT
Syndax Pharmaceuticals
SNDX
$1.7B
– –
-10,900
Closed -$61K
SUI icon
139
Sun Communities
SUI
$15.1B
– –
-1,825
Closed -$216K
TPST icon
140
Tempest Therapeutics
TPST
$14M
– –
-7,812
Closed -$31.8K
X
141
PUT
DELISTED
US Steel
X
– –
-13,900
Closed -$1.11K
XLV icon
142
CALL
State Street Health Care Select Sector SPDR ETF
XLV
$41.8B
– –
-15,400
Closed -$9.55K
XLV icon
143
PUT
State Street Health Care Select Sector SPDR ETF
XLV
$41.8B
– –
-14,600
Closed -$63.4K
XNTK icon
144
CALL
State Street SPDR NYSE Technology ETF
XNTK
$2.11B
– –
-30,800
Closed -$22.8K
XNTK icon
145
PUT
State Street SPDR NYSE Technology ETF
XNTK
$2.11B
– –
-15,400
Closed -$23.1K
ZETA icon
146
Zeta Global
ZETA
$5.62B
– –
-18,421
Closed -$154K
TFFP
147
DELISTED
TFF Pharmaceuticals, Inc. Common Stock
TFFP
– –
-25,873
Closed -$226K
GRTS
148
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
– –
-43,772
Closed -$75.3K
CAMP
149
DELISTED
CalAmp Corp.
CAMP
– –
-30,978
Closed -$289K
MRNS
150
CALL
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
– –
-49,500
Closed -$40.9K
3 4 5
6
7

Similar funds

VL
Vorpal LLC Nashville, Tennessee $32M AUM 10.89% 1-Year Est. Return
SP
SCF Partners Houston, Texas $32.2M AUM 191.71% 1-Year Est. Return
OGC
One68 Global Capital New York $30.9M AUM
PE
Platinum Equity Beverly Hills, California $32.3M AUM 17.64% 1-Year Est. Return
RL
RPO LLC Stamford, Connecticut $32.3M AUM 14.17% 1-Year Est. Return
AIIC
AJU IB Investment Company Seoul, South Korea $30.5M AUM 128.96% 1-Year Est. Return
LGM
Lykos Global Management Stamford, Connecticut $30.4M AUM
SCA
SMH Capital Advisors Fort Worth, Texas $32.9M AUM 1.53% 1-Year Est. Return

Worth Venture Partners's Q4 2023 Portfolio in Review

As of Q4 2023, Worth Venture Partners held 185 positions worth $185M, up 9.8% from $169M the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Worth Venture Partners withdrew a net $100M in Q4 2023, closing 56 positions and reducing 26 holdings. Its most notable exit was Aviat Networks, an estimated $2.34M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 16% a quarter earlier, followed by Technology and Financials.

Against the trend, Worth Venture Partners opened a new position in Electrovaya worth $2.51M.

  • Worth Venture Partners's largest Q4 2023 buy was Electrovaya: 820,538 shares worth $2.51M.
  • Worth Venture Partners added most to scPharmaceuticals in Q4 2023, an estimated $1.33M increase.
  • Worth Venture Partners's biggest Q4 2023 reduction was Apollo Global Management, cutting an estimated $662K.
  • Worth Venture Partners fully exited Aviat Networks in Q4 2023, selling an estimated $2.34M.
  • Worth Venture Partners's ten largest holdings make up 36% of its $185M portfolio in Q4 2023.
  • Worth Venture Partners opened 26 new positions and closed 56 in Q4 2023.
  • Worth Venture Partners's portfolio value rose 9.8% quarter-over-quarter to $185M.

Based on Worth Venture Partners's 13F filing for Q4 2023, filed 9 Feb 2024.